| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hematopoietic Stem Cells | 28 | 2022 | 1242 | 7.390 |
Why?
|
| Hematopoiesis | 15 | 2023 | 560 | 4.590 |
Why?
|
| Interferon-gamma | 5 | 2022 | 1144 | 1.750 |
Why?
|
| Hematologic Diseases | 3 | 2023 | 242 | 1.490 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 3 | 2022 | 310 | 1.460 |
Why?
|
| Interferon Type I | 2 | 2022 | 250 | 1.220 |
Why?
|
| Cell Differentiation | 8 | 2022 | 4078 | 1.150 |
Why?
|
| Bone Marrow | 7 | 2022 | 2358 | 1.020 |
Why?
|
| Interferon-alpha | 4 | 2018 | 889 | 0.970 |
Why?
|
| Bone Marrow Diseases | 2 | 2022 | 177 | 0.940 |
Why?
|
| Bone Marrow Cells | 5 | 2021 | 943 | 0.930 |
Why?
|
| Hematopoiesis, Extramedullary | 1 | 2023 | 41 | 0.910 |
Why?
|
| Anti-Bacterial Agents | 7 | 2021 | 2992 | 0.820 |
Why?
|
| Anemia | 2 | 2017 | 689 | 0.790 |
Why?
|
| Interferons | 2 | 2021 | 291 | 0.790 |
Why?
|
| Hematopoietic Cell Growth Factors | 1 | 2020 | 38 | 0.770 |
Why?
|
| Immunomodulation | 1 | 2022 | 242 | 0.740 |
Why?
|
| Streptococcal Infections | 3 | 2022 | 280 | 0.740 |
Why?
|
| GTP-Binding Proteins | 2 | 2011 | 321 | 0.710 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 1 | 2020 | 266 | 0.680 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2018 | 907 | 0.660 |
Why?
|
| Mice | 25 | 2022 | 34495 | 0.650 |
Why?
|
| Cell Proliferation | 8 | 2018 | 7226 | 0.640 |
Why?
|
| Hydroxyurea | 2 | 2018 | 204 | 0.640 |
Why?
|
| STAT1 Transcription Factor | 2 | 2016 | 156 | 0.640 |
Why?
|
| Bromodeoxyuridine | 1 | 2018 | 139 | 0.630 |
Why?
|
| Lymphocytic Choriomeningitis | 1 | 2017 | 15 | 0.620 |
Why?
|
| Lymphocytic choriomeningitis virus | 1 | 2017 | 19 | 0.620 |
Why?
|
| Clonal Evolution | 1 | 2019 | 253 | 0.620 |
Why?
|
| Histamine | 1 | 2017 | 53 | 0.610 |
Why?
|
| Erythroid Precursor Cells | 1 | 2017 | 61 | 0.610 |
Why?
|
| Abscess | 1 | 2019 | 177 | 0.610 |
Why?
|
| Erythropoiesis | 1 | 2017 | 74 | 0.610 |
Why?
|
| Animals | 32 | 2022 | 59536 | 0.610 |
Why?
|
| Environmental Exposure | 1 | 2019 | 288 | 0.600 |
Why?
|
| Thrombocythemia, Essential | 2 | 2018 | 162 | 0.600 |
Why?
|
| Dysbiosis | 1 | 2018 | 134 | 0.590 |
Why?
|
| Immunologic Factors | 1 | 2021 | 649 | 0.580 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2016 | 57 | 0.580 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2021 | 673 | 0.570 |
Why?
|
| Leukopenia | 1 | 2016 | 151 | 0.560 |
Why?
|
| Polycythemia Vera | 2 | 2018 | 238 | 0.560 |
Why?
|
| Busulfan | 1 | 2020 | 764 | 0.560 |
Why?
|
| Sepsis | 1 | 2022 | 652 | 0.560 |
Why?
|
| Osteomyelitis | 1 | 2019 | 236 | 0.550 |
Why?
|
| Membrane Glycoproteins | 1 | 2020 | 1073 | 0.540 |
Why?
|
| Thrombocytosis | 1 | 2016 | 121 | 0.540 |
Why?
|
| Antigens, CD | 1 | 2020 | 1385 | 0.540 |
Why?
|
| Microbiota | 1 | 2022 | 547 | 0.530 |
Why?
|
| Signal Transduction | 12 | 2022 | 11965 | 0.520 |
Why?
|
| Cat-Scratch Disease | 1 | 2015 | 35 | 0.520 |
Why?
|
| Stem Cells | 1 | 2022 | 1213 | 0.510 |
Why?
|
| Stress, Physiological | 1 | 2017 | 492 | 0.480 |
Why?
|
| Flow Cytometry | 2 | 2018 | 3033 | 0.460 |
Why?
|
| Disease Management | 1 | 2019 | 1052 | 0.450 |
Why?
|
| Cytokines | 7 | 2022 | 2809 | 0.440 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2022 | 1763 | 0.440 |
Why?
|
| Candidiasis | 2 | 2019 | 262 | 0.440 |
Why?
|
| Epithelium | 1 | 2015 | 720 | 0.430 |
Why?
|
| Receptors, Interferon | 1 | 2011 | 44 | 0.400 |
Why?
|
| Alchemy | 1 | 2011 | 3 | 0.400 |
Why?
|
| Mice, Inbred C57BL | 8 | 2022 | 6942 | 0.390 |
Why?
|
| Virus Diseases | 1 | 2015 | 398 | 0.390 |
Why?
|
| Dermis | 1 | 2011 | 65 | 0.390 |
Why?
|
| Science | 1 | 2011 | 35 | 0.380 |
Why?
|
| Cell Lineage | 4 | 2020 | 668 | 0.360 |
Why?
|
| Leprostatic Agents | 1 | 2009 | 3 | 0.350 |
Why?
|
| Adoption | 1 | 2009 | 14 | 0.350 |
Why?
|
| Immunity | 1 | 2011 | 342 | 0.340 |
Why?
|
| Leprosy | 1 | 2009 | 33 | 0.340 |
Why?
|
| Homeostasis | 4 | 2018 | 950 | 0.340 |
Why?
|
| Lipopeptides | 1 | 2009 | 114 | 0.330 |
Why?
|
| Fungemia | 1 | 2009 | 116 | 0.330 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2009 | 163 | 0.320 |
Why?
|
| Echinocandins | 1 | 2009 | 132 | 0.320 |
Why?
|
| Mutation | 7 | 2023 | 15179 | 0.310 |
Why?
|
| Epithelial Cells | 1 | 2015 | 1818 | 0.300 |
Why?
|
| Tuberculosis | 2 | 2011 | 548 | 0.300 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2009 | 193 | 0.300 |
Why?
|
| Streptococcus pyogenes | 3 | 2005 | 119 | 0.290 |
Why?
|
| Infant, Premature, Diseases | 1 | 2009 | 245 | 0.290 |
Why?
|
| Inflammation | 4 | 2022 | 2522 | 0.290 |
Why?
|
| Neoplasms | 2 | 2023 | 15193 | 0.290 |
Why?
|
| Mice, Knockout | 6 | 2017 | 5710 | 0.280 |
Why?
|
| Humans | 31 | 2023 | 261506 | 0.270 |
Why?
|
| Cell Cycle | 4 | 2018 | 2084 | 0.270 |
Why?
|
| Cell Division | 2 | 2020 | 2489 | 0.250 |
Why?
|
| Glutathione Peroxidase | 2 | 2004 | 61 | 0.250 |
Why?
|
| Myeloid Cells | 2 | 2017 | 269 | 0.250 |
Why?
|
| Fibroblasts | 1 | 2011 | 1682 | 0.240 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 5 | 2022 | 6550 | 0.240 |
Why?
|
| MicroRNAs | 1 | 2017 | 2947 | 0.240 |
Why?
|
| Leukemia Inhibitory Factor | 1 | 2023 | 39 | 0.230 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2015 | 2527 | 0.230 |
Why?
|
| Antifungal Agents | 1 | 2009 | 834 | 0.220 |
Why?
|
| Interleukin-1alpha | 1 | 2023 | 56 | 0.220 |
Why?
|
| Clone Cells | 2 | 2022 | 555 | 0.220 |
Why?
|
| Cigarette Smoking | 1 | 2023 | 88 | 0.220 |
Why?
|
| Janus Kinase 2 | 2 | 2018 | 679 | 0.210 |
Why?
|
| Peroxidases | 2 | 2005 | 29 | 0.210 |
Why?
|
| Streptococcus | 1 | 2022 | 68 | 0.210 |
Why?
|
| Radiation Chimera | 1 | 2020 | 30 | 0.190 |
Why?
|
| E-Selectin | 1 | 2020 | 103 | 0.190 |
Why?
|
| Inhalation Exposure | 1 | 2020 | 41 | 0.190 |
Why?
|
| Smoke | 1 | 2020 | 60 | 0.190 |
Why?
|
| Chemokine CXCL12 | 1 | 2020 | 132 | 0.190 |
Why?
|
| Disease Models, Animal | 5 | 2020 | 7222 | 0.180 |
Why?
|
| GPI-Linked Proteins | 1 | 2020 | 223 | 0.180 |
Why?
|
| Thyroiditis, Suppurative | 1 | 2019 | 5 | 0.180 |
Why?
|
| Candida tropicalis | 1 | 2019 | 14 | 0.180 |
Why?
|
| Hydrogen Peroxide | 1 | 2000 | 217 | 0.180 |
Why?
|
| Thyroid Crisis | 1 | 2019 | 8 | 0.180 |
Why?
|
| Protein Phosphatase 2C | 1 | 2019 | 75 | 0.180 |
Why?
|
| Tobacco Products | 1 | 2020 | 120 | 0.170 |
Why?
|
| Mycobacterium avium | 2 | 2016 | 22 | 0.170 |
Why?
|
| Toll-Like Receptors | 2 | 2018 | 174 | 0.170 |
Why?
|
| Loss of Function Mutation | 1 | 2019 | 132 | 0.170 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2011 | 4549 | 0.170 |
Why?
|
| Nod1 Signaling Adaptor Protein | 1 | 2018 | 2 | 0.170 |
Why?
|
| Bacterial Proteins | 2 | 2005 | 1029 | 0.160 |
Why?
|
| Hematologic Neoplasms | 2 | 2021 | 1870 | 0.160 |
Why?
|
| Mice, SCID | 1 | 2022 | 1869 | 0.160 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2018 | 93 | 0.160 |
Why?
|
| Models, Immunological | 1 | 2018 | 77 | 0.160 |
Why?
|
| Nutrition Disorders | 1 | 2018 | 57 | 0.160 |
Why?
|
| Interleukin-6 | 1 | 2022 | 1038 | 0.160 |
Why?
|
| Gene Expression | 3 | 2016 | 3570 | 0.150 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2011 | 5539 | 0.150 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2018 | 155 | 0.150 |
Why?
|
| Germ-Free Life | 1 | 2016 | 69 | 0.150 |
Why?
|
| Repressor Proteins | 2 | 2005 | 1664 | 0.140 |
Why?
|
| Cell Self Renewal | 1 | 2016 | 62 | 0.140 |
Why?
|
| Gene Expression Profiling | 4 | 2019 | 5159 | 0.140 |
Why?
|
| Epigenesis, Genetic | 1 | 2023 | 1399 | 0.140 |
Why?
|
| Granulocytes | 1 | 2016 | 224 | 0.140 |
Why?
|
| West Nile Fever | 1 | 2018 | 151 | 0.140 |
Why?
|
| Biomedical Research | 1 | 2023 | 806 | 0.140 |
Why?
|
| Fluorouracil | 1 | 2020 | 1944 | 0.140 |
Why?
|
| Hemoglobinuria, Paroxysmal | 1 | 2016 | 31 | 0.140 |
Why?
|
| Female | 10 | 2022 | 141928 | 0.140 |
Why?
|
| Fecal Microbiota Transplantation | 1 | 2016 | 149 | 0.140 |
Why?
|
| GATA2 Transcription Factor | 1 | 2016 | 68 | 0.130 |
Why?
|
| Glomerulonephritis, Membranoproliferative | 1 | 2015 | 23 | 0.130 |
Why?
|
| Methanococcus | 1 | 1995 | 4 | 0.130 |
Why?
|
| Zinc Fingers | 1 | 2016 | 205 | 0.130 |
Why?
|
| Stem Cell Transplantation | 1 | 2022 | 1360 | 0.130 |
Why?
|
| Societies, Scientific | 1 | 2014 | 74 | 0.130 |
Why?
|
| Resting Phase, Cell Cycle | 1 | 2014 | 35 | 0.120 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2016 | 280 | 0.120 |
Why?
|
| Graft Survival | 1 | 2018 | 1062 | 0.120 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2014 | 132 | 0.120 |
Why?
|
| Anemia, Aplastic | 1 | 2016 | 214 | 0.120 |
Why?
|
| Satellite Cells, Skeletal Muscle | 1 | 2014 | 33 | 0.120 |
Why?
|
| Polyethylene Glycols | 1 | 2018 | 615 | 0.120 |
Why?
|
| Stem Cell Niche | 1 | 2014 | 94 | 0.120 |
Why?
|
| Genes, Bacterial | 1 | 1995 | 236 | 0.120 |
Why?
|
| Myeloproliferative Disorders | 1 | 2021 | 767 | 0.120 |
Why?
|
| Neutropenia | 1 | 2018 | 968 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2016 | 479 | 0.120 |
Why?
|
| Male | 8 | 2022 | 123000 | 0.120 |
Why?
|
| Immunocompromised Host | 1 | 2018 | 698 | 0.120 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2018 | 363 | 0.110 |
Why?
|
| Hematology | 1 | 2014 | 104 | 0.110 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 4143 | 0.110 |
Why?
|
| Sequence Deletion | 1 | 2016 | 875 | 0.110 |
Why?
|
| Tumor Microenvironment | 1 | 2023 | 2864 | 0.110 |
Why?
|
| Multiprotein Complexes | 1 | 2014 | 395 | 0.100 |
Why?
|
| Treatment Failure | 1 | 2015 | 1391 | 0.100 |
Why?
|
| DNA Damage | 1 | 2019 | 1954 | 0.100 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2023 | 6915 | 0.100 |
Why?
|
| Immunophenotyping | 2 | 2016 | 1681 | 0.100 |
Why?
|
| B-Lymphocytes | 1 | 2016 | 1294 | 0.100 |
Why?
|
| Receptors, Cytokine | 1 | 2011 | 176 | 0.090 |
Why?
|
| Antiviral Agents | 1 | 2018 | 1230 | 0.090 |
Why?
|
| Transcription Factors | 2 | 2005 | 5270 | 0.090 |
Why?
|
| Protein Kinases | 1 | 1995 | 874 | 0.090 |
Why?
|
| Macrophages | 1 | 2016 | 1304 | 0.090 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2019 | 2488 | 0.090 |
Why?
|
| Pluripotent Stem Cells | 1 | 2011 | 123 | 0.090 |
Why?
|
| Ethiopia | 1 | 2009 | 24 | 0.090 |
Why?
|
| Infant | 2 | 2019 | 13310 | 0.090 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2016 | 1586 | 0.080 |
Why?
|
| Liver Function Tests | 1 | 2009 | 173 | 0.080 |
Why?
|
| Bone Marrow Transplantation | 2 | 2011 | 1581 | 0.080 |
Why?
|
| Aspartate Aminotransferases | 1 | 2009 | 153 | 0.080 |
Why?
|
| Alanine Transaminase | 1 | 2009 | 227 | 0.080 |
Why?
|
| Apoptosis | 1 | 2022 | 7591 | 0.080 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2011 | 650 | 0.080 |
Why?
|
| Cell Culture Techniques | 1 | 2011 | 598 | 0.080 |
Why?
|
| Genetic Markers | 1 | 2011 | 974 | 0.080 |
Why?
|
| Amphotericin B | 1 | 2009 | 289 | 0.080 |
Why?
|
| Texas | 1 | 2019 | 6311 | 0.080 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2014 | 1546 | 0.080 |
Why?
|
| Crohn Disease | 1 | 2011 | 351 | 0.070 |
Why?
|
| Cholestasis | 1 | 2009 | 203 | 0.070 |
Why?
|
| HEK293 Cells | 1 | 2011 | 1489 | 0.070 |
Why?
|
| Muscle, Skeletal | 1 | 2014 | 1270 | 0.070 |
Why?
|
| Antineoplastic Agents | 2 | 2021 | 14289 | 0.070 |
Why?
|
| DNA-Binding Proteins | 1 | 2019 | 4821 | 0.070 |
Why?
|
| Prednisone | 1 | 2009 | 984 | 0.070 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2019 | 2796 | 0.070 |
Why?
|
| Child | 3 | 2019 | 29154 | 0.070 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2009 | 461 | 0.070 |
Why?
|
| Peroxides | 1 | 2005 | 12 | 0.070 |
Why?
|
| Regulon | 1 | 2005 | 14 | 0.070 |
Why?
|
| Peroxiredoxins | 2 | 2005 | 17 | 0.060 |
Why?
|
| Risk Factors | 1 | 2022 | 17523 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2011 | 2508 | 0.060 |
Why?
|
| Autophagy | 1 | 2011 | 927 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 3639 | 0.060 |
Why?
|
| Alleles | 1 | 2011 | 2437 | 0.060 |
Why?
|
| Molecular Sequence Data | 4 | 2005 | 6089 | 0.060 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2005 | 192 | 0.060 |
Why?
|
| Achievement | 1 | 2023 | 41 | 0.060 |
Why?
|
| Drug Therapy, Combination | 1 | 2009 | 2315 | 0.060 |
Why?
|
| Amino Acid Sequence | 3 | 2000 | 4233 | 0.060 |
Why?
|
| Child, Preschool | 1 | 2019 | 16273 | 0.050 |
Why?
|
| Research Personnel | 1 | 2023 | 156 | 0.050 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2005 | 418 | 0.050 |
Why?
|
| DNA Modification Methylases | 1 | 2022 | 172 | 0.050 |
Why?
|
| Time Factors | 1 | 2015 | 12926 | 0.050 |
Why?
|
| Paraquat | 1 | 2000 | 19 | 0.050 |
Why?
|
| Aerobiosis | 1 | 2000 | 30 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2019 | 32848 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 4938 | 0.050 |
Why?
|
| Aging | 2 | 2022 | 1582 | 0.050 |
Why?
|
| Drug Resistance, Microbial | 1 | 2000 | 218 | 0.050 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 7548 | 0.050 |
Why?
|
| Genome, Bacterial | 1 | 2000 | 200 | 0.040 |
Why?
|
| Pulmonary Emphysema | 1 | 2020 | 145 | 0.040 |
Why?
|
| Mutagenesis | 1 | 2000 | 483 | 0.040 |
Why?
|
| Dioxygenases | 1 | 2019 | 159 | 0.040 |
Why?
|
| Adolescent | 2 | 2019 | 31252 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2019 | 276 | 0.040 |
Why?
|
| Ethanol | 1 | 2000 | 264 | 0.040 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2023 | 801 | 0.040 |
Why?
|
| Adult | 1 | 2023 | 77950 | 0.040 |
Why?
|
| Conserved Sequence | 2 | 1995 | 469 | 0.040 |
Why?
|
| Thyroidectomy | 1 | 2019 | 486 | 0.040 |
Why?
|
| Decalcification, Pathologic | 1 | 2016 | 7 | 0.040 |
Why?
|
| Side-Population Cells | 1 | 2016 | 18 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2019 | 37905 | 0.030 |
Why?
|
| Sequence Alignment | 2 | 1995 | 844 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2009 | 8223 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2018 | 829 | 0.030 |
Why?
|
| Phenotype | 2 | 2012 | 6295 | 0.030 |
Why?
|
| Eukaryotic Cells | 1 | 1995 | 45 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2016 | 518 | 0.030 |
Why?
|
| Aged | 2 | 2022 | 70117 | 0.030 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2019 | 1033 | 0.030 |
Why?
|
| Open Reading Frames | 1 | 1995 | 250 | 0.030 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 1995 | 129 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2016 | 423 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2019 | 1538 | 0.030 |
Why?
|
| Host-Pathogen Interactions | 1 | 2016 | 314 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2022 | 2022 | 0.030 |
Why?
|
| Gene Expression Regulation | 2 | 2016 | 4053 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2016 | 798 | 0.030 |
Why?
|
| Virulence | 2 | 2005 | 323 | 0.030 |
Why?
|
| Multigene Family | 1 | 1995 | 425 | 0.030 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2014 | 265 | 0.030 |
Why?
|
| Immune System | 1 | 2014 | 279 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2016 | 1163 | 0.030 |
Why?
|
| Bone and Bones | 1 | 2016 | 619 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2018 | 2927 | 0.030 |
Why?
|
| Regeneration | 1 | 2014 | 279 | 0.020 |
Why?
|
| Stromal Cells | 1 | 2014 | 825 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2018 | 5395 | 0.020 |
Why?
|
| Multipotent Stem Cells | 1 | 2010 | 52 | 0.020 |
Why?
|
| Cell Count | 1 | 2010 | 508 | 0.020 |
Why?
|
| Prognosis | 2 | 2018 | 21713 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2014 | 1048 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2014 | 1498 | 0.020 |
Why?
|
| Middle Aged | 1 | 2015 | 86204 | 0.020 |
Why?
|
| Genotype | 1 | 2016 | 4109 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 2291 | 0.020 |
Why?
|
| Neoplastic Stem Cells | 1 | 2014 | 1443 | 0.020 |
Why?
|
| Leukemia | 1 | 2014 | 1635 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2014 | 5637 | 0.020 |
Why?
|
| DNA Footprinting | 1 | 2005 | 34 | 0.020 |
Why?
|
| Oxidants | 1 | 2005 | 49 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2010 | 1819 | 0.020 |
Why?
|
| Biomarkers | 1 | 2016 | 5047 | 0.020 |
Why?
|
| DNA, Bacterial | 1 | 2005 | 558 | 0.010 |
Why?
|
| Zebrafish | 1 | 2004 | 463 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2005 | 1129 | 0.010 |
Why?
|
| Base Sequence | 1 | 2005 | 4917 | 0.010 |
Why?
|
| Skin | 1 | 2004 | 1259 | 0.010 |
Why?
|
| Protein Binding | 1 | 2005 | 3438 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2005 | 3101 | 0.010 |
Why?
|
| Glucokinase | 1 | 1995 | 21 | 0.010 |
Why?
|
| Glycerol Kinase | 1 | 1995 | 20 | 0.010 |
Why?
|
| Genes, Helminth | 1 | 1995 | 25 | 0.010 |
Why?
|
| Carbohydrates | 1 | 1995 | 68 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2004 | 4320 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1995 | 997 | 0.010 |
Why?
|
| Caenorhabditis elegans | 1 | 1995 | 268 | 0.010 |
Why?
|
| Phylogeny | 1 | 1995 | 826 | 0.010 |
Why?
|
| Databases, Factual | 1 | 1995 | 2218 | 0.000 |
Why?
|
| Software | 1 | 1995 | 1321 | 0.000 |
Why?
|